Krehlik Carrie 4
4 · Global Blood Therapeutics, Inc. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Krehlik Carrie
Chief Human Resources Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-01+49,600→ 49,600 totalExercise: $29.85Exp: 2031-08-31→ Common Stock (49,600 underlying) - Award
Restricted Stock Units
2021-09-01+32,240→ 32,240 total→ Common Stock (32,240 underlying) - Award
Restricted Stock Units
2021-09-01+42,400→ 42,400 total→ Common Stock (42,400 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in six semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F3]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F4]The stock option vests with respect to 25% of the underlying shares on August 2, 2022 and in 12 equal quarterly installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.